ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials

May 28, 1999

Scrutiny of caBIG Exposes Conflicts, Bonanza For Contractors

March 18, 2011

Feral Mouse Colony Recompetition Given Concept Approval

November 16, 1990

Project Expands Group Studies To Community Oncologists.

March 10, 2000

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

May 21, 2004

Tobacco Control: NCI Report Counters View Of Cigar Smoking As Safer Alternative

April 17, 1998